The Current State of Systemic Therapy of Metastatic Uveal Melanoma.

Am J Clin Dermatol · 2024 · PMC11358228 · PMID 38907174

Europe PMC DOI

hedged sentence

0.2570

closest p · 5.1× alpha

0.2570

boldest claim

The sentences

showed a trendp = 0.257not close (p > 0.1)

In a further retrospective multicenter study, patients treated with tebe following ICB showed a trend for a prolonged OS compared to patients treated with second-line ICB after tebe therapy (28 vs. 24 months, p = 0.257) [ 42 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.